Remedent (REMI) Income Statement
Remedent Income Statement
Last quarter (Q4 2024), Remedent's total revenue was $253.93K, an increase of 22.01% from the same quarter last year. In Q4, Remedent's net income was $-219.34K. See Remedent’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| $ 986.22K | $ 863.82K | $ 1.41M | $ 1.03M | $ 1.06M | |
| $ 603.24K | $ 505.57K | $ 1.05M | $ 578.58K | $ 742.17K | |
| $ 726.13K | $ 788.60K | $ 729.50K | $ 610.80K | $ 1.22M | |
| Depreciation and Amortization | $ 19.66K | $ 25.26K | $ 28.48K | $ 35.98K | $ 71.25K |
| $ -215.23K | $ -1.44M | $ -153.62K | $ -101.70K | $ -766.60K | |
| $ -122.89K | $ -283.03K | $ 317.48K | $ -32.22K | $ -479.61K | |
| $ -112.01K | $ -1.19M | $ -506.99K | $ -109.21K | $ -372.33K | |
| $ -234.90K | $ -1.47M | $ -189.50K | $ -141.43K | $ -851.94K | |
| $ -274.45K | $ -1.49M | $ -257.18K | $ -163.10K | $ -854.27K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.07 | $ -0.01 | $ -0.01 | $ -0.04 |
| Diluted EPS | $ -0.01 | $ -0.07 | $ -0.01 | $ -0.01 | $ -0.04 |
| Weighted Average Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Weighted Average Shares Outstanding (Diluted) | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
Currency in USD